Are genetic factors important in the aetiology of leukoaraiosis? Results from a memory clinic population, International journal of geriatric psychiatry, vol.13, issue.9, pp.585-90, 1998. ,
Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias, Archives of neurology, vol.56, issue.8, pp.961-966, 1999. ,
Dutch hereditary cerebral amyloid angiopathy: structural lesions and apolipoprotein E genotype, Annals of neurology, vol.41, issue.5, pp.695-703, 1997. ,
Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol, vol.82, issue.4, pp.239-59, 1991. ,
Evolution of the neuropathology of Alzheimer's disease, Acta Neurol Scand Suppl, vol.165, pp.3-12, 1996. ,
Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease, Archives of neurology, vol.65, issue.9, p.1202, 2008. ,
Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter? Dialogues in clinical neuroscience, vol.11, pp.181-90, 2009. ,
Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community, Archives of neurology, vol.69, issue.12, 2012. ,
Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan, Archives of neurology, vol.65, issue.8, pp.1053-61, 2008. ,
Quantitative approaches for assessment of white matter hyperintensities in elderly populations, Psychiatry research, vol.193, issue.2, pp.116-124, 2011. ,
Reduction in cerebral blood flow in areas appearing as white matter hyperintensities on magnetic resonance imaging, Psychiatry research, vol.172, issue.2, 2009. ,
White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype. Dementia and geriatric cognitive disorders, vol.10, pp.89-96, 1999. ,
Sex differences in brain aging: A quantitative magnetic resonance imaging study, Archives of neurology, vol.55, issue.2, 1998. ,
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science, vol.261, issue.5123, pp.921-924, 1993. ,
Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study, Neurosurgery & Psychiatry, vol.70, issue.1, pp.9-14, 2001. ,
Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke; a journal of cerebral circulation, vol.35, 2004. ,
apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain, J Clin Invest, vol.118, issue.12, 2008. ,
Neuropathologic basis of white matter hyperintensity accumulation with advanced age, Neurology, vol.81, issue.11, 2013. ,
Human Apolipoprotein E4 Alters the Amyloid-? 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic Model, The Journal of Neuroscience, vol.25, issue.11, 2005. ,
Risk factors for vascular dementia and Alzheimer disease, Stroke, vol.35, issue.11, 2004. ,
White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment, Alzheimers Dement, 2013. ,
Brain tissue volumes by APOE genotype and leisure activity-the AGES-Reykjavik Study, Neurobiology of aging, vol.33, issue.4, pp.1-8, 2012. ,
Effect of the apolipoprotein E epsilon4 allele on white matter hyperintensities in dementia, Stroke; a journal of cerebral circulation, vol.31, issue.6, pp.1263-1271, 2000. ,
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease, Proc Natl Acad Sci U S A, vol.97, issue.6, 2000. ,
Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT, J Nucl Med, vol.45, issue.9, p.1450, 2004. ,
Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies, Eur J Nucl Med Mol Imaging, vol.32, issue.8, pp.959-63, 2005. ,
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers, The Lancet Neurology, vol.12, issue.2, pp.70291-70291, 2013. ,
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade, The Lancet Neurology, vol.9, issue.1, pp.119-147, 2010. ,
Brain function and cognition in a community sample of elderly Latinos, Neurology, vol.59, issue.3, pp.378-83, 2002. ,
Apolipoprotein E, not fibrillar beta-amyloid, reduces cerebral glucose metabolism in normal aging, J Neurosci, vol.32, issue.50, pp.18227-18260, 2012. ,
Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer's disease, Nat Neurosci, vol.17, issue.2, pp.304-315, 2014. ,
Subclinical cerebrovascular disease in mild cognitive impairment, Neurology, vol.73, issue.6, pp.450-456, 2009. ,
Aggregation of vascular risk factors and risk of incident Alzheimer disease, Neurology, vol.65, issue.4, pp.545-51, 2005. ,
Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS, J Lipid Res, vol.50, 2009. ,
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease, Neurology, vol.45, issue.3, pp.555-562, 1995. ,
Spatial distribution of cerebral white matter lesions predicts progression to mild cognitive impairment and dementia, PloS one, vol.8, issue.2, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00916484
Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies, Ann Neurol, vol.36, issue.6, 1994. ,
Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain, Neuron, vol.15, issue.1, pp.90079-90088, 1995. ,
Differential effect of APOE genotype on amyloid load and glucose metabolism in AD dementia, Neurology, vol.80, issue.4, pp.359-65, 2013. ,
Metabolic syndrome and localization of white matter hyperintensities in the elderly population, Alzheimers Dement, vol.8, issue.5, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00715982
White Matter Hyperintensities and Cerebral Amyloidosis: Necessary and Sufficient for Clinical Expression of Alzheimer Disease?, JAMA Neurol, vol.2013 ,
Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants, Biochim Biophys Acta, vol.1822, issue.3, pp.361-370, 2012. ,
Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions, Neuron, vol.11, issue.4, pp.90070-90078, 1993. ,
Genetics of Alzheimer's Disease in Caribbean Hispanic and African American Populations, Biological psychiatry, vol.75, issue.7, pp.534-575, 2014. ,
Prevalence of DSM-IV psychiatric disorder in the French elderly population, Br J Psychiatry, vol.184, pp.147-52, 2004. ,
Stereotaxic display of brain lesions, Behavioural neurology, vol.12, issue.4, pp.191-200, 2000. ,
APOE genotype and MRI markers of cerebrovascular disease: Systematic review and meta-analysis, Neurology, vol.81, issue.3, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01171962
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality, J Neurol Neurosurg Psychiatry, vol.64, issue.1, pp.37-43, 1998. ,
A pathophysiological framework of hippocampal dysfunction in ageing and disease, Nature reviews, vol.12, issue.10, pp.585-601, 2011. ,
The APOE-e4 allele and the risk of Alzheimer's disease among African Americans, whites, and Hispanics, Journal of the American Medical Association, vol.279, pp.751-756, 1998. ,
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan, Neurology, vol.56, issue.1, pp.49-56, 2001. ,
The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics, Jama, vol.279, issue.10, pp.751-756, 1998. ,
Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes, Stroke, vol.14, issue.6, 1983. ,
Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD, Neurology, vol.67, issue.12, pp.2192-2200, 2006. ,
Microvascular injury and blood-brain barrier leakage in Alzheimer's disease, Neurobiol Aging, vol.28, issue.7, pp.977-86, 2007. ,
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders, Nat Rev Neurosci, vol.12, issue.12, 2011. ,